Skip to content

Author

Ö. Bektaş

We have 4 of 93 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Real-world efficacy and safety profile of sulthiame treatment in drug-resistant childhood epilepsy.

OBJECTIVE Sulthiame (STM) is a potent carbonic anhydrase inhibitor primarily used in focal epilepsy syndromes; however, clinical data regarding its efficacy and safety in broader drug-resistant childhood epilepsy remain limited. This study aimed to evaluate the clinical efficacy, electroencephalographic response, and s...

Nurşah Yeniay Süt, M. Yıldırım, Fatma Pınar Tabanlı et al. · 0 citations
Sep 2026

Cytotoxic Lesions of the Corpus Callosum Associated With Addison's Disease: A Case Report.

Cytotoxic Lesions of the Corpus Callosum (CLOCCs) are transient splenial lesions typically triggered by infections, trauma, or metabolic disturbances. This report documents a unique case of a 13-year-old girl with CLOCCs secondary to Addison's disease, an association not previously reported. The patient initially prese...

Nurşah Yeniay Süt, M. Yıldırım, Ö. Bektaş et al. · 0 citations
Review Aug 2026

Congenital myasthenic syndromes in Türkiye: genetic and clinical spectrum revisited in a nationwide pediatric cohort.

The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity and underscore the importance of early molecular diagnosis in a population with high consanguinity.

Canan Üstün, Ipek Polat, Gülten Öztürk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.